Clinical Trial Update: Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports the termination of a study evaluating an intravenous immunoglobulin (IVIG) treatment protocol in patients with end-stage r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Loma Linda University | Conditions: End Stage Renal Disease | NA | Status: TERMINATED | Results posted: 2016-06-06